Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Leukemia

  Free Subscription


31.10.2022

1 Acta Haematol
1 Am J Hematol
2 Blood
2 Bone Marrow Transplant
1 Cancer
1 Exp Cell Res
6 Int J Hematol
3 Leuk Lymphoma
1 Leuk Res
2 Leukemia
1 PLoS Genet
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Haematol

  1. BURGESS M, Keane C, Tobin JW, Law SC, et al
    Resolution of melanoma to PD-1 blockade but simultaneous rapid progression of concomitant chronic lymphocytic leukemia.
    Acta Haematol. 2022 Oct 21. pii: 000527631. doi: 10.1159/000527631.
    PubMed         Abstract available


    Am J Hematol

  2. ALDULESCU M, Leuer K, Jennings LJ, Yap KL, et al
    Lineage switch from acute myeloid leukemia to B-lymphoblastic lymphoma with acquired PIK3R1 loss-of-function mutation.
    Am J Hematol. 2022 Oct 26. doi: 10.1002/ajh.26770.
    PubMed        


    Blood

  3. IACOBUCCI I, Mullighan CG
    KMT2A-rearranged leukemia: the shapeshifter.
    Blood. 2022;140:1833-1835.
    PubMed        

  4. ZHAO L, Li S, Wei X, Qi X, et al
    A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL.
    Blood. 2022;140:1790-1802.
    PubMed         Abstract available


    Bone Marrow Transplant

  5. BARON F, Labopin M, Tischer J, Ciceri F, et al
    Correction: Comparison of HLA-mismatched unrelated donor transplantation with post-transplant cyclophosphamide versus HLA-haploidentical transplantation in patients with active acute myeloid leukemia.
    Bone Marrow Transplant. 2022 Oct 24. pii: 10.1038/s41409-022-01856.
    PubMed        

  6. NAGLER A, Ngoya M, Galimard JE, Labopin M, et al
    Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT.
    Bone Marrow Transplant. 2022 Oct 24. pii: 10.1038/s41409-022-01853.
    PubMed        


    Cancer

  7. YE MT, Wang Y, Zuo Z, Calin S, et al
    Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
    Cancer. 2022 Oct 25. doi: 10.1002/cncr.34515.
    PubMed         Abstract available


    Exp Cell Res

  8. YI ZN, Chen XK, Ma AC
    Modeling leukemia with zebrafish (Danio rerio): Towards precision medicine.
    Exp Cell Res. 2022 Oct 25:113401. doi: 10.1016/j.yexcr.2022.113401.
    PubMed         Abstract available


    Int J Hematol

  9. LEE FW, Lee CY, Hung GY, Tseng MH, et al
    Recurrent microangiopathic hemolysis after recovery from complement-mediated hemolytic uremia syndrome during chemotherapy for a CFH-mutated patient with T-lymphoblastic lymphoma.
    Int J Hematol. 2022;116:812-818.
    PubMed         Abstract available

  10. LI W, Xu Y, Feng Y, Zhou H, et al
    The clinical application of SNP-based next-generation sequencing (SNP-NGS) for evaluation of chimerism and microchimerism after HLA-mismatched stem cell microtransplantation.
    Int J Hematol. 2022;116:723-730.
    PubMed         Abstract available

  11. WAN L, Ding S, Xu M, Lv K, et al
    Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML.
    Int J Hematol. 2022;116:731-743.
    PubMed         Abstract available

  12. YUNIS LK, Linares-Ballesteros A, Barros G, Garcia J, et al
    Genomic alterations in a cohort of pediatric acute myeloid leukemia patients at two cancer centers in Colombia.
    Int J Hematol. 2022 Oct 24. pii: 10.1007/s12185-022-03475.
    PubMed         Abstract available

  13. ITO J, Yamagata K, Shinohara H, Shima Y, et al
    Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1.
    Int J Hematol. 2022 Oct 24. pii: 10.1007/s12185-022-03469.
    PubMed         Abstract available

  14. VINOTHKUMAR K, Chanda S, Singh VK, Biswas S, et al
    EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells.
    Int J Hematol. 2022 Oct 25. pii: 10.1007/s12185-022-03465.
    PubMed         Abstract available


    Leuk Lymphoma

  15. BEWERSDORF JP, Shallis RM, Derkach A, Goldberg AD, et al
    Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors.
    Leuk Lymphoma. 2022 Oct 26:1-9. doi: 10.1080/10428194.2022.2136952.
    PubMed         Abstract available

  16. SHAHZAD M, Chaudhary SG, Tariq E, Mushtaq AH, et al
    Use of endpoints in phase III randomized controlled trials for acute myeloid leukemia over the last 15 years: a systematic review.
    Leuk Lymphoma. 2022 Oct 25:1-10. doi: 10.1080/10428194.2022.2136947.
    PubMed         Abstract available

  17. HELFGOTT DC, Racine-Brzostek S, Short KJ, Zhao Z, et al
    Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Leuk Lymphoma. 2022 Oct 25:1-9. doi: 10.1080/10428194.2022.2131414.
    PubMed         Abstract available


    Leuk Res

  18. KING AC, Derkach A, Weis TM, Stump SE, et al
    Real-world analysis of the safety/tolerability of gilteritinib in combination with mold-active azole prophylaxis.
    Leuk Res. 2022;122:106929.
    PubMed        


    Leukemia

  19. COUSINS A, Olivares O, Markert E, Manoharan A, et al
    Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways.
    Leukemia. 2022 Oct 26. pii: 10.1038/s41375-022-01722.
    PubMed        

  20. GARCIA-GISBERT N, Arenillas L, Roman-Bravo D, Rodriguez-Sevilla JJ, et al
    Multi-hit TET2 mutations as a differential molecular signature of oligomonocytic and overt chronic myelomonocytic leukemia.
    Leukemia. 2022 Oct 22. pii: 10.1038/s41375-022-01733.
    PubMed        


    PLoS Genet

  21. CHIRICHES C, Nicolaisen N, Wieske M, Elhaddad H, et al
    Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.
    PLoS Genet. 2022;18:e1010463.
    PubMed         Abstract available


    PLoS One

  22. SZELEST M, Masternak M, Zajac M, Chojnacki M, et al
    The role of NPM1 alternative splicing in patients with chronic lymphocytic leukemia.
    PLoS One. 2022;17:e0276674.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: